期刊文献+

p57^(Kip2)和Ki-67在壶腹癌中的表达及意义 被引量:1

The Expression of p57^(Kip2) and Ki-67 in Carcinomas of the Ampulla of Vater
下载PDF
导出
摘要 目的:研究壶腹癌中p57Kip2和Ki-67的表达及其与肿瘤的发生和进展的关系。方法:采用免疫组织化学ABC法检测46 例原发性壶腹癌,4例壶腹部腺瘤和8例壶腹部正常组织手术切除标本的p57Kip2和Ki-67表达水平。结果:46例壶腹癌的p57Kip2标志指数(labeling index,LI)平均为44.8%±24.6%,明显低于壶腹部正常上皮64.9%±11.3%(P=0.017)。腺瘤的p57Kip2LI平均为62.3%±2.8%,与正常上皮表达相比无显著差异。p57Kip2LI在淋巴结转移(33.2%vs 57.5%;P=0.001), 十二指肠浸润(40.8%vs 59.3%;P=0.04),胰腺浸润(38.9%vs 55.9%;P=0.019)以及高TNM分期(Ⅲ期或Ⅳ期vs Ⅰ期或Ⅱ期,33.2%vs 57.5%;P=0.001)病例中显著降低。Ki-67高表达与壶腹癌的淋巴结转移(69.7%vs 49.2%;P=0.001 2),十二指肠浸润(64.7%vs 42.6%;P=0.006),胰腺浸润(65.8%vs 48.8%;P=0.012),高TNM分期(Ⅲ期或Ⅳ期vs Ⅰ期或Ⅱ期,69.7%vs 49.2%;P=0.0012)呈显著相关。p57Kip2表达与Ki-67表达呈负相关(P=0.001)。结论:在壶腹癌的发生和进展过程中,p57Kip2失活不是一个早期基因事件,而是一个相对较晚的事件,与肿瘤的进展和淋巴结转移相关。Ki-67是反映壶腹癌进展的一个重要指标。 Objective:To investigate p57Kip2 and Ki-67 expression in human carcinomas and adenomas of the ampulla of vater. Methods: We examed the expression of p57Kip2 and Ki-67 immunohistochemically in 8 normal ampullas,4 adenomas, and 46 adenocarcinomas of the ampulla of vater by using avidin - biotin complex method. Results: The p57Kip2 labeling index (LI) in adenocarcinomas of the ampulla of vater was 44. 8% ± 24. 6% averagely, and was significantly lower than in normal ampullas (64.9% ± 11.3%,P = 0.017). The p57Kip2 LI in adenomas was 62.3% ±2.8% averagely, and was not significantly changed compared to the normals. p57Kip2 LI was significantly reduced in cases with lymph node metastasis (33.2% vs 57.5%; P = 0. 001), invasion of duodenal wall (40. 8% vs 59. 3% ; P = 0. 04), invasion of pancreatic parenchyma (38. 9% vs 55. 9%;P = 0.019) and advanced TNM stage (Ⅲ and Ⅳ vs Ⅰ and Ⅱ ,33.2% vs 57. 5%; P = 0.001). However, high Ki-67 LI was significantly correlated with tumor lymph node metastasis (69. 7% vs. 49. 2% ;P = 0. 0012) .invasion of duodenal wall (64. 7% vs. 42. 6%;P= 0. 006),invasion of pancreatic parenchyma (65. 8% vs. 48. 8%;P = 0. 012) and advanced TNM stage (Ⅲ and Ⅳ vs. Ⅰ and Ⅱ ,69. 7% vs. 49. 2% ;P = 0. 0012). The expression of p57Kip2 was inversely correlated with Ki-67 expression (P = 0. 001). Conclusion: The down-regulation of p57Kip2 is a common event in carcinogenesis of the Ampulla of Vater. Dysfunction of p57Kip2 is a late event contributed to tumor malignant progression and lymph metastasis in this kind of tumors. The Ki-67 index is a useful marker for tumor progression of carcinoma of the Ampulla of Vater.
出处 《中国临床医学》 北大核心 2005年第1期91-94,共4页 Chinese Journal of Clinical Medicine
基金 中国博士后科学基金资助(N02003034294)
关键词 P57^KIP2 壶腹癌 KI-67 肿瘤 表达 浸润 淋巴结转移 平均 指标 标志 p57Kip2 Ki-67 Carcinomas of the ampulla of Vater Immunohistochemistry
  • 相关文献

参考文献14

  • 1Zhao B,Kimura W,Futakawa N,et al. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater. Am J Gastroenterol [J], 1999,94: 2128-2134.
  • 2Lee MH, Reynisdottir I , Massague J: Cloning of p57KIP2 a cyclin dependent kinase inhibitor with unique domain structure and tissue distribution[J]. Genes Dev, 1995; 9: 639-649.
  • 3Nakai S,Masaki T,Shiratori Y,et al. Expression of p57(KIP2)in hepatocellular carcinoma: relationship between tumor differentiation and patient survival. Int J Oncol, 2002,20: 769-775.
  • 4Ito Y,Takeda T,Sasaki Y,et al. Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma[J]. Liver, 2002,22: 145-149.
  • 5Ito Y,Takeda T,Wakasa K,et al. Expression of p57/Kip2 protein in pancreatic adenocarcinoma. Pancreas, 2001,23: 246-250.
  • 6Li X, Hui AM,Shi YZ,et al. Deregulation of G1/S transition is a common event in carcinoma of the ampulla of vater[J]. Hepatogastroenterology,2002,49:1239- 1244.
  • 7Hui AM,Shi YZ,Li X,et al. Proliferative marker Ki-67 in gallbladder carcinomas: high expression level predicts early recurrence after surgical resection[J]. Cancer Lett, 2002, 176:191 - 198.
  • 8Howe JR,Klimstra DS,Cordon-Cardo C,et al. K-ras mutation in adenomas and carcinomas of the ampulla of vater[J]. Clin Cancer Res, 1997,3:129-133.
  • 9Younes M, Riley S, Genta RM, et al. p53 protein accumulation in tumors of theampulla of Vater. Cancer, 1995,76:1150-1154.
  • 10Tokino T, Urano T, Furuhata T, et al. Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis[J]. Hum Genet, 1996,97: 625-631.

同被引文献11

  • 1唐杰荣,王志明,陈湘,肖圣华,杨孜.p27^(KIP1)、p57^(KIP2)在甲状腺癌中的表达及临床意义[J].中国医师杂志,2004,6(11):1506-1508. 被引量:5
  • 2周峻,金岩,董绍忠,杨连甲.舌鳞癌组织中cyclinA和cyclin D1的基因转录[J].肿瘤防治杂志,2004,11(5):482-484. 被引量:4
  • 3Watanabe H,Pan ZQ,Schreiber-Agus N,et al. Suppression of call transfor by the cyclindependent kinase inhibitor p57^KiP2 requires binding to pro-liferating cell nuclear antigen[J].Biochemistry,1998,95(4):1392-1397.
  • 4Mutsuoka S,Edwards MC,Bai C,et al.p57^KiP2,a structurally distinct member of the p57^KiP2 CDK inhibitor family, is a candicate tumor suppressor gene [J].Genes Dev,1995,9(6):650-662p57^KiP2.
  • 5Reid LH,Crider-miller SJ,West A,et al.Genomic organization of the human p57^Kip2 gene and its analysis in the G401 Wilms tumor assay[J].Cancer Res, 1996,56(6): 1214-1218.
  • 6Mutsuoka S,Thompson JS,Edwards MC,et al.Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor,p57^KiP2,on chromosome 11P15[J].Proc Natl Acad Sci USA, 1996,93:3026-3030.
  • 7Thompson JS,Reese KJ,Debaun MR,et al.Reduced expression of the cyclin-dependent kinase inhibitor gene p57^KiP2 in Wilm tumor[J].Cancer Res, 1996,56:5723 -5727.
  • 8Ito Y,Yoshida H:Nakano K,et al.Expression of p57^KiP2 protein in normal and neoplastic thyroid tissues [J].Int J MOL Med,2002,9(4).373-376.
  • 9Fan GK,Chen J,Ping F.Immunohistochemical analysis of p57^KiP2,p53 and hsp60 expressions in premalignant and malignant oral tissues[J].Oral Oncol, 2006,42(2}: 147-153.
  • 10Chao Y, Shih YL,Chiu GY, et al.Overexpression of cyclin A but not skp2 correlates with the relapse of human hepatocelluler carcinoma[J].Carcer Res. 1998.58:985-990.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部